Biotech & MedTech News
-
Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant
November 29, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
FendX Announces Publication of Data on Antimicrobial Properties of a New Nanotechnology Film Formulation that Both Repels and Kills Bacteria
Repel and kill film formulation shows approximately 99.8% reduction in adhesion of bacteria to the surface and at…
-
FendX Technologies to Present at the SHARE(TM) Series Monday Management Update on December 4, 2023
November 28, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
-
Zentek Announces Update on the Albany Graphite Project
November 21, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company provides…
-
Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
November 16, 2023 (Source) — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
Zentek Reports Improvements and Expansion of its Aptamer-Based Platform Technology
November 15, 2023 (Source) — Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization…
-
FendX Provides Corporate Update
November 15, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”), a…
-
FendX to Conduct Second Pilot Run on Dunmore’s Commercial Manufacturing Line for Further Development of REPELWRAP(TM) Film
November 7, 2023 (Source) — FendX Technologies Inc. (CSE:FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology company…
-
Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis
November 1, 2023 (Source) — Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage life sciences…
-
FendX Announces Issuance of a Patent in China to Protect REPELWRAP(TM) Film
November 1, 2023 (Source) — FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the “Company” or “FendX”) a nanotechnology…
